Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1994
Prophylaxis of superficial bladder cancer with mitomycin or interferon alfa-2b: results of a multicentric Italian studyF Boccardo, D Cannata, A Rubagotti, et al.
International Journal of Radiation Oncology, Biology, Physics|August 30, 1995
Alternating chemo-radiotherapy in bladder cancer: a conservative approachM Orsatti, A Curotto, L Canobbio, et al.
European Journal of Cancer & Clinical Oncology|October 1, 1987
Sequential combination of tamoxifen and high dose medroxyprogesterone acetate: therapeutic and endocrine effects in postmenopausal advanced breast cancer patientsG Gasparini, L Canobbio, E Galligioni, et al.
American Journal of Clinical Oncology|October 1, 1988
Chemotherapy of advanced non-small-cell lung cancer with cyclophosphamide, adriamycin, methotrexate, and procarbazine versus cisplatin and etoposide. A randomized studyA Veronesi, M D Magri, U Tirelli, et al.
Cancer Treatment Reports|July 1, 1986
Etoposide and high-dose cisplatin in good-risk patients with advanced squamous cell carcinoma and adenocarcinoma of the lungA Ardizzoni, L Canobbio, P Pronzato, et al.
The Cancer Journal From Scientific American|July 1, 1997
Predictive factors for outcome in invasive bladder cancer treated with alternating chemoradiotherapyG Sanguineti, M Orsatti, M P Sormani, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1992
Randomised comparison of weekly bolus 5-fluorouracil with or without leucovorin in metastatic colorectal carcinomaM T Nobile, R Rosso, M R Sertoli, et al.
American Journal of Clinical Oncology|October 1, 1987
Sequential administration of cyclophosphamide, methotrexate, 5-fluorouracil, and folinic acid as salvage treatment in metastatic breast cancerP Pronzato, D Amoroso, A Ardizzoni, et al.
Cancer Chemotherapy and Pharmacology|February 18, 2011
Bi-weekly docetaxel and gemcitabine regimen in her-2-negative and anthracycline-pretreated metastatic breast cancer patients: a multicenter phase II trialR Murialdo, F Bertolotti, G Pastorino, et al.
Tumori|December 23, 1998
Interleukin-2, interferon-alpha and interleukin-2 plus interferon-alpha in renal cell carcinoma. A randomized phase II trialF Boccardo, A Rubagotti, L Canobbio, et al.
Pageof 4